ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Electronic Health Record"

  • Abstract Number: 466 • 2018 ACR/ARHP Annual Meeting

    Improving Pneumococcal Vaccination Rates in Childhood-Onset SLE Patients at a Large Tertiary Care Center: The Path to Creating a More Sustainable Model of Vaccination with the Help of EMR

    Saimun Singla and Marietta M. De Guzman, Pediatric Immunology, Allergy and Rheumatology, Baylor College of Medicine, Texas Children's Hospital, Houston, TX

    Background/Purpose: Streptococcus pneumonia is a leading cause of illness in children worldwide and can lead to death in those with an immunosuppressed status. Given the…
  • Abstract Number: 1164 • 2018 ACR/ARHP Annual Meeting

    Canadians’ Views about Using Big Data in Health Research from a National Online Survey: A Partnership of Patient-Consumers and Researchers

    Natalie McCormick1, Clayon Hamilton1,2, Cheryl L. Koehn3, Kelly English4, Allan Stordy5 and Linda Li1,6, 1Arthritis Research Canada, Richmond, BC, Canada, 2Physical Therapy, The University of British Columbia, Vancouver, BC, Canada, 3Arthritis Consumer Experts, Vancouver, BC, Canada, 4Arthritis Patient Advisory Board, Arthritis Research Canada, Richmond, BC, Canada, 5Canadian Skin Patient Alliance, Calgary, AB, Canada, 6Department of Physical Therapy, The University of British Columbia, Vancouver, BC, Canada

    Background/Purpose:                  Findings from health research using “big data” (large sets of routinely-collected healthcare data) have benefitted individual arthritis patients and society as-a-whole.  However, growing…
  • Abstract Number: 1242 • 2018 ACR/ARHP Annual Meeting

    Rheumatologists Participating in the RISE Registry Succeeded in the First Year of the Merit-Based Incentive Payment System (MIPS)

    Tracy Johansson1, Ryan Larosa2, Rachel Myslinski3, Norlita Brown1, Lindsay Lewis1 and Jinoos Yazdany4, 1Practice, Advocacy & Quality, American College of Rheumatology, Atlanta, GA, 2American College of Rheumatology, Atlanta, GA, 3Practice, Advocacy, & Quality, American College of Rheumatology, Atlanta, GA, 4University of California, San Francisco, San Francisco, CA

    Background/Purpose: Under the Medicare Access and CHIP Reauthorization Act (MACRA), rheumatologists face financial repercussions through the Merit-Based Incentive Payment System (MIPS) based on performance on…
  • Abstract Number: 1408 • 2018 ACR/ARHP Annual Meeting

    Using Patient Reported Outcomes at Point of Care in Immune Mediated Diseases: Minimal Clinically Important Differences

    M. Elaine Husni1, Chad Deal2, Leonard H. Calabrese3, Greg Strnad4, James Bena5 and Abby Abelson6, 1Orthopedic and Rheumatologic Institute, Cleveland Clinic, Cleveland, OH, 2Cleveland Clinic, Shaker Heights, OH, 3Rheumatology, Cleveland Clinic, Cleveland, OH, 4Cleveland Clinic, Cleveland, OH, 5Quantitative Health Science, QHS Cleveland Clinic, Cleveland, OH, 6Department of Rheumatologic & Immunologic Disease, Cleveland Clinic, Cleveland, OH

    Background/Purpose: Patient reported measures of global health and disease activity are increasingly used in routine care; however, detecting meaningful change in clinical status (responsiveness) is difficult…
  • Abstract Number: 1686 • 2018 ACR/ARHP Annual Meeting

    Rule-Based Algorithm Using Systemic Lupus International Collaborating Clinics (SLICC) Classification Criteria to Identify Patients with Systemic Lupus Erythematosus (SLE) from Electronic Health Record (EHR) Data

    Anika S. Ghosh1, Theresa L. Walunas2, Kathryn L. Jackson1, Ahn H. Chun3, Daniel L. Erickson3, Karen Mancera-Cuevas4, Abel N. Kho3 and Rosalind Ramsey-Goldman5, 1Center for Health Information Partnerships, Northwestern University, Chicago, IL, 2Department of Medicine, Division of General Internal Medicine and Geriatrics, Northwestern University, Chicago, IL, 3Northwestern University, Chicago, IL, 4Rheumatology, Northwestern University, Chicago, IL, 5FSM, Northwestern University, Chicago, IL

    Background/Purpose: Systemic Lupus Erythematosus (SLE) is an autoimmune disease that can affect many parts of the body including skin, lungs, brain, heart, kidneys, joints, and…
  • Abstract Number: 1692 • 2018 ACR/ARHP Annual Meeting

    Using ICD-10-CM Codes to Identify Patients with Systemic Lupus Erythematosus in the Electronic Health Record

    April Barnado1, Robert Carroll2, Joshua C. Denny2 and Leslie Crofford1, 1Division of Rheumatology and Immunology, Vanderbilt University Medical Center, Nashville, TN, 2Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN

    Background/Purpose: The electronic health record (EHR) serves as a powerful tool to enable researchers to collect a large cohort of patients across the healthcare system. …
  • Abstract Number: 1891 • 2018 ACR/ARHP Annual Meeting

    Patterns of Biosimilar Use in the Rheumatology Informatics System for Effectiveness (RISE) Registry

    Nick Bansback1, Jeffrey R. Curtis2, Jie Huang3, Lindsay Lewis4, Tracy Johansson4, Kaleb Michaud5 and Katherine P. Liao3, 1St Paul's Hospital, Centre for Health Evaluation and Outcomes Sciences, Vancouver, BC, Canada, 2University of Alabama at Birmingham, Birmingham, AL, 3Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, MA, 4Practice, Advocacy & Quality, American College of Rheumatology, Atlanta, GA, 5Rheumatology, University of Nebraska Medical Center, Omaha, NE

    Background/Purpose: In the U.S., the first biosimilar tumor necrosis inhibitor (TNFi) was approved in 2016.  To date, only biosimilars for infliximab are available in the…
  • Abstract Number: 2115 • 2018 ACR/ARHP Annual Meeting

    Identification of Systemic Lupus Erythematosus Subgroups Using Electronic Health Record and Genetic Databases

    Milena Gianfrancesco1, Ishan Paranjpe2, Julia Kay3, Joanne Nitiham4, Kimberly Taylor5, Cristina Lanata1, Marina Sirota6, Lindsey A. Criswell7, Gabriela Schmajuk8 and Jinoos Yazdany2, 1Medicine/Rheumatology, University of California, San Francisco, San Francisco, CA, 2University of California, San Francisco, San Francisco, CA, 3Medicine/Rheumatology, University of California - San Francisco, San Francisco, CA, 4Rosalind Russell / Ephraim P. Engleman Rheumatology Research Center, University of California, San Francisco, San Francisco, CA, 5University of California, San Francisco, Rosalind Russell / Ephraim P. Engleman Rheumatology Research Center, San Francisco, CA, 6Pediatrics, Institute for Computational Health Sciences, University of California, San Francisco, San Francisco, CA, 7University of California San Francisco, San Francisco, CA, 8San Francisco VA Medical Center, San Francisco, CA

    Background/Purpose: Systemic lupus erythematosus (SLE) is a multifactorial disease with genetic and environmental risk factors, and heterogeneous manifestations that encompass a wide range of disease…
  • Abstract Number: 2134 • 2018 ACR/ARHP Annual Meeting

    Modifiable Risk Factors and the Development of Psoriatic Arthritis in People with Psoriasis

    Amelia Green1,2, Gavin Shaddick3, Rachel Charlton1, Julia Snowball1, Alison L Nightingale1, Catherine Smith4, William Tillet1,5 and Neil McHugh1,5, 1Department of Pharmacy and Pharmacology, The University of Bath, Bath, United Kingdom, 2Department of Mathematical Sciences, The University of Bath, Bath, United Kingdom, 3Centre for Data Science and Statistics, The University of Exeter, Bath, United Kingdom, 4Guy’s and St Thomas’ NHS Foundation Trust, St John’s Institute of Dermatology, London, United Kingdom, 5Royal National Hospital for Rheumatic Diseases, Bath, UK, Bath, United Kingdom

    Background/Purpose: Psoriatic Arthritis (PsA) is a progressive and often destructive joint disease that causes pain, swelling and joint stiffness, and can lead to an impaired…
  • Abstract Number: 206 • 2018 ACR/ARHP Annual Meeting

    Impact of International Classification of Diseases 10th Revision Codes and Updated Medical Information on an Existing Rheumatoid Arthritis Phenotype Algorithm Using Electronic Medical Data

    Sicong Huang1, Jie Huang1, Tianrun Cai2, Kumar P. Dahal3, Andrew Cagan4, Jacklyn Stratton3, Tianxi Cai5 and Katherine P. Liao3, 1Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, MA, 2Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital, Boston, MA, 3Brigham and Women's Hospital, Boston, MA, 4Research Computing, Partners HealthCare, Charlestown, MA, 5Harvard T.H. Chan School of Public Health, Boston, MA

    Background/Purpose: Electronic medical records (EMRs) are increasingly being utilized for clinical research, where the phenotypes of interest are typically defined by algorithms.  Almost a decade…
  • Abstract Number: 2152 • 2018 ACR/ARHP Annual Meeting

    A Comparison of the American College of Rheumatology (ACR) and Systemic Lupus International Collaborating Clinics Classification (SLICC) Criteria to Detect Patients with Systemic Lupus Erythematosus (SLE) in Electronic Health Record (EHR) Data

    Theresa L. Walunas1, Anika S. Ghosh2, Kathryn L. Jackson3, Ahn H. Chun2, Daniel L. Erickson2, Karen Mancera-Cuevas4, Abel N. Kho2 and Rosalind Ramsey-Goldman5, 1Department of Medicine, Division of General Internal Medicine and Geriatrics, Northwestern University, Chicago, IL, 2Northwestern University, Chicago, IL, 3Center for Health Information Partnerships, Northwestern University, Chicago, IL, 4Rheumatology, Northwestern University, Chicago, IL, 5FSM, Northwestern University, Chicago, IL

    Background/Purpose: Systemic Lupus Erythematosus is a systemic autoimmune disease that has diverse manifestations that can occur over a long period of time. The complexity of…
  • Abstract Number: 295 • 2018 ACR/ARHP Annual Meeting

    Implementing a Staff Tobacco Cessation Protocol Increases Quit Line Referrals in a Community Rheumatology Practice

    Ann M. Chodara1, Edmond Ramly2,3, Douglas White4, Heather Johnson5, Andrea Gilmore-Bykovskyi6 and Christie M. Bartels7, 1Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI, 2Industrial and Systems Engineering, University of Wisconsin College of Engineering, Madison, WI, 3Department of Family Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI, 4Gundersen Lutheran - Onalaska Clinic, Onalaska, WI, 5Cardiology/Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI, 6University of Wisconsin School of Nursing, Madison, WI, 7Rheumatology/Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI

    Background/Purpose: Smoking remains the leading preventable cause of US mortality and predicts higher incidence, greater severity, and reduced treatment response in many rheumatologic conditions. Despite…
  • Abstract Number: 2174 • 2018 ACR/ARHP Annual Meeting

    Self-Report of Fracture History Compared to Fracture Codes from an Electronic Health Record Dataset

    Maria I. Danila1, Amy S. Mudano1, Elizabeth J. Rahn2, Andrea Z. LaCroix3,4, Jeffrey R. Curtis1 and Kenneth Saag1, 1University of Alabama at Birmingham, Birmingham, AL, 2Department of Medicine, Division of Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL, 3University of California San Diego, La Jolla, CA, 4Group Health Cooperative, Seattle, WA

    Background/Purpose: Self-reported fracture (fx) history data is frequently used in epidemiological studies of osteoporosis. Self-reported fx data may differ from fx history coded in electronic…
  • Abstract Number: 333 • 2018 ACR/ARHP Annual Meeting

    Electronic Delivery of Patient-Reported Outcome Questionnaires on Tablet PCs at Clinic Visit: A Feasibility Study

    Thomas Grader-Beck1, Michelle Jones2, Ana-Maria Orbai2 and Clifton O. Bingham III3, 1Medicine (Rheumatology), Johns Hopkins University School of Medicine, Baltimore, MD, 2Johns Hopkins University School of Medicine, Baltimore, MD, 3Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD

    Background/Purpose: Assessment of patient-reported outcomes (PROs) at clinic visits has emerged as an important component to determine disease activity in Rheumatoid Arthritis (RA). However, paper-based…
  • Abstract Number: 2180 • 2018 ACR/ARHP Annual Meeting

    Differences in Longitudinal Disease Activity Measures between Research Cohort and Non-Cohort Participants with Rheumatoid Arthritis Using Electronic Health Record Data

    Milena Gianfrancesco1, Laura Trupin1, Charles McCulloch2, Stephen Shiboski3, Jonathan Graf4, Gabriela Schmajuk5 and Jinoos Yazdany6, 1Medicine/Rheumatology, University of California, San Francisco, San Francisco, CA, 2Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, 3Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, 4Department of Medicine, Division of Rheumatology Zuckerberg San Francisco General Hospital, University of California, San Francisco, San Francisco, CA, 5San Francisco VA Medical Center, San Francisco, CA, 6University of California, San Francisco, San Francisco, CA

    Background/Purpose: Research using electronic health records (EHR) may offer advantages over traditional observational studies, including lower costs and greater generalizability to a broader patient population;…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 6
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology